Detection of new drug indications from electronic medical records

@article{Dang2016DetectionON,
  title={Detection of new drug indications from electronic medical records},
  author={Tran-Thai Dang and Phetnidda Ouankhamchan and Tu-Bao Ho},
  journal={2016 IEEE RIVF International Conference on Computing & Communication Technologies, Research, Innovation, and Vision for the Future (RIVF)},
  year={2016},
  pages={223-228}
}
  • Tran-Thai Dang, Phetnidda Ouankhamchan, Tu-Bao Ho
  • Published 2016
  • Medicine, Computer Science
  • 2016 IEEE RIVF International Conference on Computing & Communication Technologies, Research, Innovation, and Vision for the Future (RIVF)
  • Drug repositioning — detection of new uses of existing drugs — is an emerging trend in pharmaceutical industry. It essentially is a multiple aspect process of analyzing large-scale heterogeneous data for exploiting advantage of off-targets of the existing drugs. Three kinds of omics, phenomic and drug data are often integrated and used to study drug repositioning. The recent prevalence of electronic medical records (EMRs) makes it become an extremely significant resource of phenomic data for… CONTINUE READING
    3 Citations

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    References

    SHOWING 1-10 OF 29 REFERENCES
    Exploiting drug-disease relationships for computational drug repositioning
    • 317
    • PDF
    A survey of current trends in computational drug repositioning
    • 236
    • PDF
    Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
    • 176
    • PDF
    In Vitro Screening for Drug Repositioning
    • 23
    Automated Detection of Off-Label Drug Use
    • 45
    • PDF
    Data-driven Approach to Detect and Predict Adverse Drug Reactions.
    • 23
    • PDF